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Abstract
Background: Adenomatoid tumors are regarded as distinctive benign mesothelial neoplasms of
the paratesticular region, most commonly occuring at the tail of the epididymidis.
Because of its rarity, the clinical and histopathological aspects are discussed.
Case presentation: We present the case of a 41-year-old patient with an adenomatoid tumour
located in the tail of the left epididymis that referred to our department with gradual enlarged
intrascrotal mass. The diagnosis was achieved by echography, and was confirmed by surgical
excision and histological analysis.
Conclusion: Due to its low incidence in intrascrotal pathology, we believe it is important for the
physician to be aware of this interesting entity in order to make a differential diagnosis from other
inflammatory processes and to adopt the proper surgical approach.
Background
A variety of neoplasms derived from mesenchymal ele-
ments may arise on the patatesticular tissues. The diagnos-
tic considerations may include carcinoma of rete testis,
malignant mesothelioma, ovarian-type epithelial tumors,
epididymidal carcinoma and metastatic carcinoma. Ade-
nomatoid tumors were first described in 1945 by Golden
et al as a small firm asymptomatic intrascrotal mass, with
no pain or tenderness, occurring in third to fifth decades
of life. The origin of the adenomatoid tumor is not clear,
although the structural and immunohistochemical stud-
ies support the mesothelial origin. The histological pat-
tern of the tumor is characterized by tubules, cords, and
small nests, formed of cuboidal cells with vacuolated
cytoplasm, and we may discriminate three kinds of ade-
nomatoid tumor:plexiform, glandular and angiomatoid.
The elected treatment is orchiectomy and epididymec-
tomy, a probably aggressive surgical treatment which in
combination with immunohistological confirmation are
essential to resolve a formidable diagnostic challenge.
Case presentation
A 41 years old man referred to our department for painless
enlargement in the left hemiscrotum. Personal and famil-
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ial history were unremarkable, without epididymitis, tor-
sion or trauma. On physical examination, a hard,
painless, firm, intrascrotal mass at the lower pole of the
left testis was revealed, apparently distinct from the testis
and arising directly from the surface of the left epididymis.
Scrotal skin epididymis, spermatic cord, inguinal region
and right testis were normal.
Ultrasonography confirmed a solid isoechoic lesion lying
on the border between epididymal tail and lower pole of
the left testis, without any disruption of the architecture of
the testical parenchyma. The testicular parenchyma
immediately adjacent to the mass showed slightly
degreased echogenity compared with the parenchyma
elsewhere. Preoperative laboratory investigation, includ-
ing hemogram, blood chemistry studies were within nor-
mal limits. Plasma levels of β-hCG (β-subunit human
chronic gonadotropin), α-fetoprotein (AFP), lactic dehy-
drogenase (LDH) were within normal ranges. The first
clinical impression was a probable germ cell neoplasm.
The patient subsequently underwent a total left orchiec-
tomy-epididymectomy, which revealed a white, crescent-
shaped, well circumscribed tumor, about 1,5 cm, without
involvement of the testicular parenchyma.
Histological appearance of this paratesticular tumor is
represented by cuboidal cells, with vacuolated cytoplasm
and with gaping spaces (Fig. 1). The neoplasmatic cells
had lymphoplasmacytic and eosinophilic infiltration,
which varied in intensity, from scan to moderate dense,
and especially the presence of prominent lymphoid aggre-
gates, particularly towards the periphery of the neoplasm,
is a helpful clue to the diagnosis of the adenomatoid
tumor (Fig. 2). The cellular vacuoles had a signet ring-like
appearance in some fields but epithelial type mucin was
not present There was no mitotic activity and no suspi-
cious neoplasmatic areas in testicular parenchyma was
been detected.
Immunohistochemical positivity for mesothelial marker
HMBE1 (mouse anti-human antigen mesothelial cell)
and calretinin confirm the mesothelial origin of the tumor
(Fig. 3, 4). This tumor was diagnosed as an adenomatoid
tumor in the epididymis and the patient underwent no
additional treatment.
Discussion
Paratesticular tumors are uncommon and comprise less
than 5% of all intrascrotal tumors. Epididydimal epithe-
lial tumors are a rare subtype of paratesticular tumors with
the adenomatoid tumor being most common followed by
the papillary cystadenoma and the leiomyoma [1]. These
tumors usually arises in the epididymis, and approxi-
mately 14% of paratesticular adenomatoid tumors arise
from the testicular tunica [2]. Except from epididymis,
adenomatoid tumor can be located in spermatic cord,
prostate, ejaculatory ducts, and scrotal capes and in
female can be located in uterus, Fallopian tubes and ovar-
ian area. It can be seen in all ages, but are most common
in the third to forth decades of life [3].
Histological pattern of neoplasmatic cells Figure 1
Histological pattern of neoplasmatic cells. Adenoma-
toid tumor with gaping spaces represented by cuboidal cells, 
with vacuolated cytoplasm (hematoxylene-eosine, ×40).
Histological pattern of neoplasmatic cells Figure 2
Histological pattern of neoplasmatic cells. Adenoma-
toid tumor with peripheral lemphoplasmatic infiltration par-
ticularly towards the periphery of the neoplasm, 
(hematoxylene-eosine, ×40).Cases Journal 2008, 1:206 http://www.casesjournal.com/content/1/1/206
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Adenomatoid tumors present as a relatively small well
demarked, without capsule nodule, less than 2 cm in
diameter. The largest diameter that has been reported is
12 cm [2]. Most adenomatoid tumors of epididymis are
asymptomatic and are found accidentally by the patient
or by the physician on physical examination, as a non
painful inscrotal mass commonly found in the tail of the
epidydimis, which generally remains unchanged in size
for years[4].
The tumor has a plethora of microscopic appearances,
represented by three basic patterns:tubules, cords, and
small nests, formed of cells that are cuboidal with vacu-
olated cytoplasm also characterized by peripheral eosi-
nophilic and lymphatic infiltration [5]. Gaping spaces
with no evident lining, representing a necrotic tubular
component, and smaller spaces, representing ghost rem-
nants of the typical vacuolar spaces, are major clues to the
diagnosis. The differential diagnosis includes metastatic
carcinoma, malignant mesothelioma, hystocytoid
hemangioma, and carcinoma of the rete testis. Immuno-
histochemical confirmation with mesothelial-related
markers (calretinin, HMBE1) is helpful in the differential
with nonmeshothelial lesions [6].
The possible histogenesis of adenomatoid tumors has
aroused controversy and our data, so far, are contradic-
tory. However, the most recent investigations favor a mes-
othelial origin [7,8] and other pathologists have
considered it to be a reaction to injury or inflammation.
However, it is difficult to find such irritating factors in
intrascrotal adenomatoid tumors. There is no case of
malignant contact or presence of metastases [9].
In conclusion adenomatoid tumor of the epididymis is a
distinctive clinical identity with much differential diagno-
sis, hard to distinguish; the cornerstone of accurate char-
acterization of the tumor is still a comprehensive,
traditional clinicopathologic approach, clinical history,
routine light microscopy and immunohistochemical
markers are crucial for the correct diagnosis.
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